Cathie Wood Goes Bargain Hunting: 1 "Magnificent Seven" Artificial Intelligence (AI) Stock She Just Couldn't Pass Up During the Nasdaq Sell-Off
4 Articles
4 Articles
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics - ARK Genomic Revolution ETF (BATS:ARKG), ARK Innovation ETF (BATS:ARKK)
On Friday, April 11, 2025, Cathie Wood-led Ark Invest executed notable trades, shedding shares in UiPath Inc. (NYSE:PATH), Prime Medicine Inc. (NGM: PRME), and Repare Therapeutics Inc. (NASDAQ:RPTX). The PATH Trade Ark Invest’s ARK Innovation ETF (NYSE:ARKK) fund sold 4,256 shares of UiPath Inc. Based on the closing price of $10.87 on the day of the trade, the total value of the transaction amounts to approximately $46,280.32. UiPath’s stock saw…


Cathie Wood Goes Bargain Hunting: 1 "Magnificent Seven" Artificial Intelligence (AI) Stock She Just Couldn't Pass Up During the Nasdaq Sell-Off
In This Article: Cathie Wood is the CEO and Chief Investment Officer of Ark Invest, which offers a small catalog of innovation-focused exchange-traded funds (ETFs). Those funds' portfolios tend to be dominated by smaller, speculative companies in emerging industries. While these investment…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage